PE20141219A1 - Profarmaco de adrenomedulina basado en polietilenglicol y su uso - Google Patents
Profarmaco de adrenomedulina basado en polietilenglicol y su usoInfo
- Publication number
- PE20141219A1 PE20141219A1 PE2014000540A PE2014000540A PE20141219A1 PE 20141219 A1 PE20141219 A1 PE 20141219A1 PE 2014000540 A PE2014000540 A PE 2014000540A PE 2014000540 A PE2014000540 A PE 2014000540A PE 20141219 A1 PE20141219 A1 PE 20141219A1
- Authority
- PE
- Peru
- Prior art keywords
- amino
- ethyl
- adrenomedulin
- polyethylene glycol
- compounds
- Prior art date
Links
- -1 POLYETHYLENE Polymers 0.000 title abstract 2
- 229940002612 prodrug Drugs 0.000 title abstract 2
- 239000000651 prodrug Substances 0.000 title abstract 2
- 239000004698 Polyethylene Substances 0.000 title 1
- 229920000573 polyethylene Polymers 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 239000002202 Polyethylene glycol Substances 0.000 abstract 2
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 abstract 2
- 229920001223 polyethylene glycol Polymers 0.000 abstract 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11187735 | 2011-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20141219A1 true PE20141219A1 (es) | 2014-09-13 |
Family
ID=47146369
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2014000540A PE20141219A1 (es) | 2011-11-03 | 2012-10-30 | Profarmaco de adrenomedulina basado en polietilenglicol y su uso |
| PE2018001536A PE20181493A1 (es) | 2011-11-03 | 2012-10-30 | Profarmaco de adrenomedulina basado en polietilenglicol y su uso |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2018001536A PE20181493A1 (es) | 2011-11-03 | 2012-10-30 | Profarmaco de adrenomedulina basado en polietilenglicol y su uso |
Country Status (45)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014010806A2 (pt) * | 2011-11-03 | 2017-05-02 | Bayer Ip Gmbh | ligadores à base de tirosina para a ligação reversível de peptídeos |
| EP2896400A1 (en) * | 2014-01-17 | 2015-07-22 | Université Catholique De Louvain | Method for increasing the bioavailability of inhaled compounds |
| JP6685046B2 (ja) * | 2014-03-20 | 2020-04-22 | 国立大学法人 宮崎大学 | 長時間作用型アドレノメデュリン誘導体 |
| CN107001440A (zh) | 2014-09-26 | 2017-08-01 | 拜耳制药股份公司 | 稳定化的肾上腺髓质素衍生物及其用途 |
| KR102152437B1 (ko) * | 2015-09-18 | 2020-09-07 | 고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 | 장시간 작용형 아드레노메둘린 유도체 |
| JP7001285B2 (ja) | 2017-03-29 | 2022-01-19 | 国立大学法人 宮崎大学 | 長時間作用型アドレノメデュリン誘導体 |
| GB201707938D0 (en) * | 2017-05-17 | 2017-06-28 | Univ Sheffield | Compounds |
| CA3143584A1 (en) | 2019-06-18 | 2020-12-24 | Bayer Aktiengesellschaft | Adrenomedullin-analogues for long-term stabilization and their use |
| CA3151983A1 (en) * | 2019-09-21 | 2021-03-25 | Ozgul TEZGEL | Dmso-free synthesis of oligopeptide-modified poly(beta-amino ester)s and their use in nanoparticle delivery systems |
| JP7498882B2 (ja) * | 2019-12-05 | 2024-06-13 | 国立大学法人 宮崎大学 | 異常タンパク質蓄積性神経変性疾患の治療剤 |
| EP4126062A1 (en) * | 2020-04-03 | 2023-02-08 | Bayer Aktiengesellschaft | Liquid pharmaceutical formulations polyethylene glycol-based prodrugs of adrenomedullin and use |
| IL297014A (en) * | 2020-04-03 | 2022-12-01 | Bayer Ag | Pharmaceutical formulations polyethylene glycol-based prodrugs of adrenomedullin and use |
| AU2021341508A1 (en) | 2020-09-10 | 2023-05-25 | Precirix N.V. | Antibody fragment against fap |
| CN112457218B (zh) * | 2020-11-05 | 2022-08-09 | 宁夏医科大学 | 2,4-二氨基丁酸衍生物的合成方法 |
| IL310248A (en) | 2021-08-20 | 2024-03-01 | Bayer Ag | Process for the preparation of pegylated adrenomedullin, its intermediates and use thereof |
| WO2023203135A1 (en) | 2022-04-22 | 2023-10-26 | Precirix N.V. | Improved radiolabelled antibody |
| AU2023264245A1 (en) | 2022-05-02 | 2024-12-19 | Precirix N.V. | Pre-targeting |
| WO2025133215A1 (en) | 2023-12-22 | 2025-06-26 | Pam Theragnostics Gmbh | Use of inactive adrenomedullin precursor for therapeutic purposes |
| WO2025133225A1 (en) | 2023-12-22 | 2025-06-26 | Pam Theragnostics Gmbh | Pharmaceutical combination of peptide-gly and peptidylglycine alpha-amidating monooxygenase (pam) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5020040A (en) * | 1987-06-24 | 1991-05-28 | Digital Equipment Corporation | Overwriting system for magneto-optical recording with self timing track |
| US4812590A (en) * | 1987-06-25 | 1989-03-14 | Merck & Co., Inc. | Carbamates of 4-hydroxyanisole as prodrugs for chemotherapy of melanoma |
| US6090800A (en) | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
| US6624142B2 (en) | 1997-12-30 | 2003-09-23 | Enzon, Inc. | Trimethyl lock based tetrapartate prodrugs |
| CA2292902C (en) | 1999-12-24 | 2012-12-18 | Alain Cadieux | Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases |
| EP1243276A1 (en) | 2001-03-23 | 2002-09-25 | Franciscus Marinus Hendrikus De Groot | Elongated and multiple spacers containing activatible prodrugs |
| US20050271615A1 (en) | 2002-08-30 | 2005-12-08 | Doron Shabat | Self-immolative dendrimers releasing many active moieties upon a single activating event |
| WO2004043493A1 (en) | 2002-11-14 | 2004-05-27 | Syntarga B.V. | Prodrugs built as multiple self-elimination-release spacers |
| JP4629671B2 (ja) | 2003-07-23 | 2011-02-09 | ピーピージー・インダストリーズ・オハイオ・インコーポレイテッド | 複合封止装置および窓組立体 |
| CA2786794C (en) | 2004-03-23 | 2017-09-12 | Complex Biosystems Gmbh | Aromatic polymeric cascade prodrug linker reagent |
| CA2567478C (en) | 2004-05-24 | 2014-04-01 | Institut De Cardiologie De Montreal | Labelled adrenomedullin derivatives and their use for imaging and therapy |
| GB2427360A (en) | 2005-06-22 | 2006-12-27 | Complex Biosystems Gmbh | Aliphatic prodrug linker |
| US8273325B2 (en) * | 2006-12-20 | 2012-09-25 | Ge Healthcare As | Contrast agents |
| DK2155781T3 (da) | 2007-05-11 | 2013-06-17 | Inst Cardiologie Montreal | Mærkede adrenomedullinderivater og deres anvendelse til visualisering og terapi |
| EP2525831B1 (en) | 2010-01-22 | 2019-05-15 | Ascendis Pharma A/S | Carrier-linked carbamate prodrug linkers |
| BR112014010806A2 (pt) * | 2011-11-03 | 2017-05-02 | Bayer Ip Gmbh | ligadores à base de tirosina para a ligação reversível de peptídeos |
-
2011
- 2011-11-03 JO JOP/2019/0001A patent/JOP20190001B1/ar active
-
2012
- 2012-10-24 JO JOP/2012/0324A patent/JO3385B1/ar active
- 2012-10-29 UY UY0001034419A patent/UY34419A/es unknown
- 2012-10-29 UY UY0001037922A patent/UY37922A/es active IP Right Grant
- 2012-10-30 RS RS20160172A patent/RS54623B1/sr unknown
- 2012-10-30 CN CN201280053588.6A patent/CN103998063B/zh not_active Expired - Fee Related
- 2012-10-30 MX MX2017011334A patent/MX361287B/es unknown
- 2012-10-30 PE PE2014000540A patent/PE20141219A1/es active IP Right Grant
- 2012-10-30 PH PH1/2014/500998A patent/PH12014500998A1/en unknown
- 2012-10-30 BR BR112014010708-4A patent/BR112014010708B1/pt not_active IP Right Cessation
- 2012-10-30 UA UAA201405818A patent/UA111098C2/uk unknown
- 2012-10-30 SI SI201230498A patent/SI2773376T1/sl unknown
- 2012-10-30 EP EP12783566.8A patent/EP2773376B1/en active Active
- 2012-10-30 CA CA2854134A patent/CA2854134C/en active Active
- 2012-10-30 ES ES12783566.8T patent/ES2568063T3/es active Active
- 2012-10-30 KR KR1020147013845A patent/KR101965467B1/ko not_active Expired - Fee Related
- 2012-10-30 SG SG11201400924TA patent/SG11201400924TA/en unknown
- 2012-10-30 PL PL15192265T patent/PL3075395T3/pl unknown
- 2012-10-30 CN CN201610837728.9A patent/CN107412740B/zh not_active Expired - Fee Related
- 2012-10-30 EP EP15192265.5A patent/EP3075395B1/en active Active
- 2012-10-30 AU AU2012331244A patent/AU2012331244B2/en not_active Ceased
- 2012-10-30 IN IN3290CHN2014 patent/IN2014CN03290A/en unknown
- 2012-10-30 LT LTEP15192265.5T patent/LT3075395T/lt unknown
- 2012-10-30 AR ARP120104059A patent/AR088582A1/es not_active Application Discontinuation
- 2012-10-30 WO PCT/EP2012/071507 patent/WO2013064508A1/en not_active Ceased
- 2012-10-30 JP JP2014539315A patent/JP5995984B2/ja not_active Expired - Fee Related
- 2012-10-30 PE PE2018001536A patent/PE20181493A1/es unknown
- 2012-10-30 NO NO15192265A patent/NO3075395T3/no unknown
- 2012-10-30 MY MYPI2014701087A patent/MY173372A/en unknown
- 2012-10-30 ES ES15192265.5T patent/ES2659195T3/es active Active
- 2012-10-30 RS RS20180141A patent/RS56819B1/sr unknown
- 2012-10-30 HU HUE15192265A patent/HUE036535T2/hu unknown
- 2012-10-30 EA EA201400528A patent/EA025631B1/ru not_active IP Right Cessation
- 2012-10-30 MX MX2014004384A patent/MX350341B/es active IP Right Grant
- 2012-10-30 DK DK12783566.8T patent/DK2773376T3/en active
- 2012-10-30 ME MEP-2016-56A patent/ME02379B/me unknown
- 2012-10-30 SI SI201231218T patent/SI3075395T1/en unknown
- 2012-10-30 KR KR1020187027464A patent/KR102004668B1/ko not_active Expired - Fee Related
- 2012-10-30 HU HUE12783566A patent/HUE027333T2/en unknown
- 2012-10-30 PL PL12783566T patent/PL2773376T3/pl unknown
- 2012-10-30 SG SG10201607516SA patent/SG10201607516SA/en unknown
- 2012-10-30 PT PT151922655T patent/PT3075395T/pt unknown
- 2012-10-30 EA EA201600495A patent/EA029410B1/ru not_active IP Right Cessation
- 2012-10-30 HR HRP20160285TT patent/HRP20160285T1/hr unknown
- 2012-10-30 DK DK15192265.5T patent/DK3075395T3/en active
- 2012-10-30 TR TR2018/02124T patent/TR201802124T4/tr unknown
- 2012-10-30 MY MYPI2018001427A patent/MY194197A/en unknown
- 2012-10-30 US US14/355,568 patent/US9603936B2/en not_active Expired - Fee Related
- 2012-11-02 TW TW106104340A patent/TWI653051B/zh not_active IP Right Cessation
- 2012-11-02 TW TW101140660A patent/TWI583396B/zh not_active IP Right Cessation
-
2014
- 2014-04-09 IL IL232037A patent/IL232037B/en active IP Right Grant
- 2014-04-10 CO CO14078051A patent/CO7020863A2/es unknown
- 2014-04-14 CL CL2014000948A patent/CL2014000948A1/es unknown
- 2014-04-15 DO DO2014000078A patent/DOP2014000078A/es unknown
- 2014-04-23 CR CR20140184A patent/CR20140184A/es unknown
- 2014-04-28 MA MA36961A patent/MA35618B1/fr unknown
- 2014-04-28 EC ECSP14013326 patent/ECSP14013326A/es unknown
- 2014-04-29 CU CUP2014000051A patent/CU24184B1/es active IP Right Grant
- 2014-04-30 GT GT201400085A patent/GT201400085A/es unknown
- 2014-04-30 TN TNP2014000185A patent/TN2014000185A1/en unknown
-
2015
- 2015-12-31 US US14/986,488 patent/US9649363B2/en not_active Expired - Fee Related
-
2016
- 2016-01-20 ZA ZA2016/00434A patent/ZA201600434B/en unknown
- 2016-04-12 CY CY20161100293T patent/CY1117354T1/el unknown
- 2016-08-23 JP JP2016162327A patent/JP6177975B2/ja not_active Expired - Fee Related
-
2017
- 2017-03-29 US US15/472,476 patent/US10035818B2/en active Active
- 2017-05-15 IL IL252281A patent/IL252281B/en active IP Right Grant
- 2017-05-22 AU AU2017203423A patent/AU2017203423B2/en not_active Ceased
-
2018
- 2018-02-07 CY CY20181100151T patent/CY1119897T1/el unknown
- 2018-02-21 HR HRP20180319TT patent/HRP20180319T1/hr unknown
- 2018-03-19 IL IL258229A patent/IL258229B/en active IP Right Grant
- 2018-09-20 EC ECSENADI201871104A patent/ECSP18071104A/es unknown
- 2018-09-20 DO DO2018000203A patent/DOP2018000203A/es unknown
- 2018-11-05 AR ARP180103212A patent/AR113830A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201190306A1 (ru) | Улучшенная липидная композиция | |
| EP2529442A4 (en) | PHASE STABLE DOTED ZIRCONIUM ELECTROLYTE COMPOSITIONS WITH LOW DECOMPOSITION | |
| CY1119269T1 (el) | Θεραπεια βλαβων που προκαλουνται απο ιους | |
| EA201190320A1 (ru) | Гетероциклические сульфонамиды, их применения и фармацевтические композиции | |
| EA201492011A1 (ru) | Безводные фармацевтические составы для местного применения | |
| BR112014012358A2 (pt) | 2-oxo-1,3-dioxolano-4-carboxamidas, sua preparação e uso | |
| CO6680667A2 (es) | Derivados ester de ácido borónico cíclico y sus usos terapéuticos | |
| PE20150181A1 (es) | Variantes de oxm pegilada | |
| EA201500653A1 (ru) | Композиции, содержащие триазольное соединение | |
| EP2538784A4 (en) | NEW CYCLIC BENZIMIDAZOLE DERIVATIVES AS ANTIDIABETICS | |
| EA201270216A1 (ru) | Фармацевтический состав | |
| AR060030A1 (es) | Diesteres de acidos carboxilicos ramificados | |
| PE20181493A1 (es) | Profarmaco de adrenomedulina basado en polietilenglicol y su uso | |
| BR112013023174A2 (pt) | "compostos derivados de triterpenoide de c4-monometila, composição farmacêutica compreendendo os referidos compostos e uso dos mesmos" | |
| EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
| ECSP10010722A (es) | Compuestos orgánicos | |
| MX395271B (es) | Composicion farmaceutica. | |
| BR112013004662B8 (pt) | Composto, composição farmacêutica, usos de um composto, e método para preparar uma composição farmacêutica | |
| EA201201298A1 (ru) | Фунгицидные композиции, содержащие фосфорастворимый микроорганизм и фунгицидно активное соединение | |
| WO2013006743A3 (en) | Personal care compositions with improved solubility of a solid cosmetic active substance | |
| DK2627202T3 (da) | Anvendelse af en sammensætning omfattende et antimikrobielt peptid som et fødevarekonserveringsmiddel | |
| BR112012016797A2 (pt) | intensificador dinâmico de baixo utilizando compressor com equalizador incorporado | |
| BR112012007842A2 (pt) | um copolímero em bloco e composição de poliesteramida com terminação éster e usos dos mesmos | |
| EA201201623A1 (ru) | Лечение диабета 2 типа | |
| BR112014004523A2 (pt) | composto e composição aromatizante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |